{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:16:28Z","timestamp":1773202588008,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.bcp.2023.115442","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T01:39:12Z","timestamp":1675042752000},"page":"115442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK\/miR-22\/HuR axis in chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"209","author":[{"given":"Yuan-Chin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Ting","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115442_b0005","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2023.115442_b0010","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcp.2023.115442_b0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and Resistance to BCR-ABL1-Targeted Therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2023.115442_b0020","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood.2021014689","article-title":"Asciminib: a new therapeutic option in chronic-phase CML with treatment failure","volume":"139","author":"Yeung","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115442_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/524308","article-title":"The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias","volume":"2012","author":"Tzifi","year":"2012","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.bcp.2023.115442_b0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2018.11.005","article-title":"Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia","volume":"686","author":"Chandran","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2023.115442_b0035","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"Aichberger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115442_b0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41419-021-04154-0","article-title":"Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells","volume":"12","author":"Malyukova","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2023.115442_b0045","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.3390\/ijms21113907","article-title":"Albendazole-induced SIRT3 upregulation protects human leukemia K562 cells from the cytotoxicity of MCL1 suppression","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115442_b0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/embor.2011.65","article-title":"Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS","volume":"12","author":"Chen","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2023.115442_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114857","article-title":"Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells","volume":"387","author":"Chiou","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115442_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2021.04.006","article-title":"AMPK signaling and its targeting in cancer progression and treatment","volume":"85","author":"Hsu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2023.115442_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-cancerbio-030419-033619","article-title":"AMP-activated protein kinase: friend or foe in cancer?","volume":"4","author":"Vara-Ciruelos","year":"2020","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.bcp.2023.115442_b0070","article-title":"New insights into activation and function of the AMPK","author":"Steinberg","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115442_b0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","article-title":"AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow","volume":"17","author":"Saito","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2023.115442_b0080","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1182\/blood-2011-01-332783","article-title":"Antileukemic effects of AMPK activators on BCR-ABL-expressing cells","volume":"118","author":"Vakana","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115442_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110197","article-title":"AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia","volume":"38","author":"Grenier","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2023.115442_b0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cas.14698","article-title":"AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells","volume":"112","author":"Koyama","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2023.115442_b0095","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1038\/onc.2014.301","article-title":"Differential effects of AMPK agonists on cell growth and metabolism","volume":"34","author":"Vincent","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2023.115442_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4939-7598-3_12","article-title":"Compound C\/Dorsomorphin: Its use and misuse as an AMPK inhibitor","volume":"1732","author":"Dasgupta","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2023.115442_b0105","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1107\/S0907444911010201","article-title":"Structural basis for compound C inhibition of the human AMP-activated protein kinase \u03b12 subunit kinase domain","volume":"67","author":"Handa","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bcp.2023.115442_b0110","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.embor.7400536","article-title":"Bcr is a negative regulator of the Wnt signalling pathway","volume":"6","author":"Ress","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2023.115442_b0115","doi-asserted-by":"crossref","first-page":"11576","DOI":"10.1158\/0008-5472.CAN-07-2756","article-title":"MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells","volume":"67","author":"Kawano","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2023.115442_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8166-3-15","article-title":"Genomic amplification of BCR\/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines","volume":"3","author":"Virgili","year":"2010","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.bcp.2023.115442_b0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2018.06.019","article-title":"ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells","volume":"432","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2023.115442_b0130","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/mnfr.201200167","article-title":"Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr\/Abl","volume":"56","author":"Chen","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bcp.2023.115442_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109978","article-title":"BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells","volume":"361","author":"Chiou","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2023.115442_b0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/BJ20110725","article-title":"Adaphostin promotes caffeine-evoked autocrine Fas-mediated death pathway activation in Bcr\/Abl-positive leukaemia cells","volume":"439","author":"Liu","year":"2011","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2023.115442_b0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2023.115442_b0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4161\/auto.7.1.13883","article-title":"Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt\/mTOR pathway","volume":"7","author":"Vucicevic","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2023.115442_b0155","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1002\/jcb.26723","article-title":"Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt\/mTOR-independent pathway","volume":"119","author":"Zhao","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2023.115442_b0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10565-019-09495-3","article-title":"Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS\/p38 MAPK\/AMPK\/TET2\/FOXP3 axis","volume":"36","author":"Chiou","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2023.115442_b0165","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrm2256","article-title":"ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis","volume":"8","author":"D'Autr\u00e9aux","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115442_b0170","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2011.06.033","article-title":"Cross talk between mitochondria and NADPH oxidases","volume":"51","author":"Dikalov","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2023.115442_b0175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/leu.2012.338","article-title":"AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells","volume":"27","author":"Accordi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2023.115442_b0180","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00018-008-8170-7","article-title":"The complexity of mitogen-activated protein kinases (MAPKs) made simple","volume":"65","author":"Krishna","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2023.115442_b0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.1997.6849","article-title":"Novel homologues of CSBP\/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles","volume":"235","author":"Kumar","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2023.115442_b0190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/1541-7786.MCR-10-0325","article-title":"The RNA-binding protein HuR promotes glioma growth and treatment resistance","volume":"9","author":"Filippova","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2023.115442_b0195","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI80631","article-title":"The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection","volume":"127","author":"Ebner","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115442_b0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-017-0751-3","article-title":"The Jun\/miR-22\/HuR regulatory axis contributes to tumourigenesis in colorectal cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2023.115442_b0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.seminhematol.2014.05.008","article-title":"Targeting BCL2 for the treatment of lymphoid malignancies","volume":"51","author":"Anderson","year":"2014","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcp.2023.115442_b0210","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1038\/sigtrans.2017.12","article-title":"Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells","volume":"2","author":"Luedtke","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2023.115442_b0215","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1038\/cddis.2013.419","article-title":"Implication of transcriptional repression in compound C-induced apoptosis in cancer cells","volume":"4","author":"Dai","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2023.115442_b0220","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.yexcr.2010.04.028","article-title":"Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1","volume":"316","author":"Jang","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2023.115442_b0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115442_b0230","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.3390\/cancers10010018","article-title":"mTOR pathways in cancer and autophagy","volume":"10","author":"Paquette","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2023.115442_b0235","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/1535-7163.MCT-13-0579","article-title":"The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent","volume":"13","author":"Liu","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2023.115442_b0240","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7150\/ijbs.39936","article-title":"Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway","volume":"16","author":"Wu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2023.115442_b0245","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1194\/jlr.M900119-JLR200","article-title":"AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells","volume":"50","author":"Jin","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2023.115442_b0250","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1248\/bpb.b15-00938","article-title":"Compound C Increases Sestrin2 Expression via Mitochondria-Dependent ROS Production","volume":"39","author":"Seo","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bcp.2023.115442_b0255","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1111\/cas.13781","article-title":"Alternating magnetic field enhances cytotoxicity of Compound C","volume":"109","author":"Akimoto","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2023.115442_b0260","doi-asserted-by":"crossref","first-page":"C50","DOI":"10.1152\/ajpcell.90654.2007","article-title":"Regulation of H2O2-induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes","volume":"295","author":"Saberi","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2023.115442_b0265","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cmet.2013.12.013","article-title":"A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation","volume":"19","author":"Shao","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2023.115442_b0270","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.freeradbiomed.2021.02.018","article-title":"Oxidative stress-mediated AMPK inactivation determines the high susceptibility of LKB1-mutant NSCLC cells to glucose starvation","volume":"166","author":"Ren","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2023.115442_b0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation","volume":"9","author":"Karin","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115442_b0280","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s001090050063","article-title":"Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways","volume":"74","author":"Whitmarsh","year":"1996","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bcp.2023.115442_b0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/bjh.16044","article-title":"SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation","volume":"187","author":"Ma","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcp.2023.115442_b0290","doi-asserted-by":"crossref","first-page":"43390","DOI":"10.18632\/oncotarget.9717","article-title":"Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia","volume":"7","author":"Qiao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2023.115442_b0295","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115442_b0300","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.18632\/oncotarget.413","article-title":"AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications","volume":"2","author":"Vakana","year":"2011","journal-title":"Oncotarget"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:43:28Z","timestamp":1757771008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"alternative-id":["S0006295223000333"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115442","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK\/miR-22\/HuR axis in chronic myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115442"}}